Vantage Consulting Group Inc
- SEC CIK
- 0001843547
- Latest filing
- Feb 11, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 12, 2025. Long positions only; changes compare share counts with Q3 2024.
- Positions
- 5
- +1 vs. Q3 2024
- Portfolio value
- $10.5M
- −$923.8K (−8.1%) vs. Q3 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BWBabcock & Wilcox Enterprises, Inc. | COM | 2,416,200 | $3.96M | 37.8% | 00.0% | Unchanged | History |
| CBUSCibus, Inc. | CL A COM STK | 1,143,949 | $3.18M | 30.3% | 00.0% | Unchanged | History |
| ADCTADC Therapeutics SA | SHS | 850,737 | $1.69M | 16.1% | 00.0% | Unchanged | History |
| PBPBPotbelly Corp | COM | 164,875 | $1.55M | 14.8% | +164,875 | New | History |
| KYNBKyntra Bio, Inc. | COM | 195,707 | $103.6K | 1.0% | 00.0% | Unchanged | History |